TY - JOUR T1 - Maternal and child gluten intake and risk of type 1 diabetes: The Norwegian Mother and Child Cohort Study JF - medRxiv DO - 10.1101/19001883 SP - 19001883 AU - Nicolai A Lund-Blix AU - German Tapia AU - Karl Mårild AU - Anne Lise Brantsaeter AU - Pål R Njølstad AU - Geir Joner AU - Torild Skrivarhaug AU - Ketil Størdal AU - Lars C Stene Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/07/19/19001883.abstract N2 - OBJECTIVE To examine the association between maternal and child gluten intake and risk of type 1 diabetes in children.DESIGN Pregnancy cohortSETTING Population-based, nation-wide study in NorwayPARTICIPANTS 86,306 children in The Norwegian Mother and Child Cohort Study born from 1999 through 2009, followed to April 15, 2018.MAIN OUTCOME MEASURES Clinical type 1 diabetes, ascertained in a nation-wide childhood diabetes registry. Hazard ratios were estimated using Cox regression for the exposures maternal gluten intake up to week 22 of pregnancy and child’s gluten intake when the child was 18 months old.RESULTS During a mean follow-up of 12.3 years (range 0.7-16.0), 346 children (0.4%) developed type 1 diabetes (incidence rate 32.6 per 100,000 person-years). The average gluten intake was 13.6 grams/day for mothers during pregnancy, and 8.8 grams/day for the child at 18 months of age. Maternal gluten intake in mid-pregnancy was not associated with the development of type 1 diabetes in the child (adjusted hazard ratio 1.02 (95% confidence interval 0.73 to 1.43) per 10 grams/day increase in gluten intake). However, the child’s gluten intake at 18 months of age was associated with an increased risk of later developing type 1 diabetes (adjusted hazard ratio 1.46 (95% confidence interval 1.06 to 2.01) per 10 grams/day increase in gluten intake).CONCLUSIONS This study suggests that the child’s gluten intake at 18 months of age, and not the maternal intake during pregnancy, could increase the risk of type 1 diabetes in the child.WHAT IS ALREADY KNOWN ON THIS TOPIC A national prospective cohort study from Denmark found that a high maternal gluten intake during pregnancy could increase the risk of type 1 diabetes in the offspring (adjusted hazard ratio 1.31 (95% confidence interval 1.001 to 1.72) per 10 grams/day increase in gluten intake). No studies have investigated the relation between the amount of gluten intake by both the mother during pregnancy and the child in early life and risk of developing type 1 diabetes in childhood.WHAT THIS STUDY ADDS In this prospective population-based pregnancy cohort with 86,306 children of whom 346 developed type 1 diabetes we found that the child’s gluten intake at 18 months of age was associated with the risk of type 1 diabetes (adjusted hazard ratio 1.46 (95% confidence interval 1.06 to 2.01) per 10 grams/day increase in gluten intake). This study suggests that the child’s gluten intake at 18 months of age, and not the maternal intake during pregnancy, could increase the child’s risk of type 1 diabetes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, NIH/NIEHS (contract no N01-ES-75558), NIH/NINDS (grant no.1 UO1 NS 047537-01 and grant no.2 UO1 NS 047537-06A1). The sub-study was funded by a research grant from the Research Council of Norway (grant 2210909/F20, to Lars C Stene). Nicolai A Lund-Blix was supported by a grant from Helse Sør-Øst, Norway. Ketil Størdal was supported by an unrestricted grant from Oak Foundation, Geneva, Switzerland. Pål R Njølstad was supported by grants from the Norwegian Research Council (#240413) and Helse Vest (Strategic Grant PERSON-MED-DIA, and #12270). The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. All researchers was independent from funders, and all authors had full access to the data and takes responsibility for the integrity of the data and the accuracy of the data analysis.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesCodes for the statistical analyses are available upon request. Access to data can be obtained by sending an application to The Norwegian Mother and Child Cohort Study (E-mail: dataaccess{at}fhi.no, information website: https://www.fhi.no/en/op/data-access-from-health-registries-health-studies-and-biobanks/data-from-moba/moba-research-data-files/) https://www.fhi.no/en/op/data-access-from-health-registries-health-studies-and-biobanks/data-from-moba/moba-research-data-files/ ER -